Business
Voyageur Sets 2020 Goals & Reviews 2019 Milestones to Become a Fully-Integrated Pharmaceutical Manufacturing Company
(via TheNewswire) Dear Shareholders, I would like to thank all our stak...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Sets 2020 Goals & Reviews 2019 Milestones to Become a Fully-Integrated Pharmaceutical Manufacturing Company(via TheNewswire)\n \n \nDear Shareholders,\n\n \n \nI would like to thank all our stakeholders, particularly our shareholders, for supporting and believing in Voyageur and our continuing transformation from an industrial mineral miner into a fully-integrated pharmaceutical company. 2019 was a year of transformation toward creation of maximum value for our shareholders. The founders, Brad Willis and myself, who each have over 30 years' experience in the barium sulfate industry, recognized a major opportunity to realize the highest value possible from the Company's Frances Creek barium sulfate project. Our goal, and mine specifically as CEO, is to responsibly create the highest return for shareholders. \n\n \n \nMany in the mining industry are content to create a mineral concentrate and ship it to mid-markets for others to create products from those minerals. It is our strategy that all efforts be made to create as many end-user products as possible, to enable the company to achieve the highest profit margins possible. Our joint venture with Chief Medical Supply Ltd. is designed around the goal of Voyageur becoming an integral producer of pharmaceutical radio-contrast products.\n\n \n \nVoyageur is currently focused on becoming a fully-integrated pharmaceutical company by creating USP (US Pharmacopeia) grade minerals. USP minerals are used as active pharmaceutical ingredients (API's) in not only barium related products, but all pharmaceutical products that relate to the many minerals that Voyageur is creating access to.\n\n \n \nBy implementing our strategy of creating barium sulfate based products for sale directly to the pharmaceutical customer, Voyageur's aim is to create the highest net profit per tonne in the natural barium sulfate industry. In 2019, our strategy of \"From the Earth to the Bottle\" was born. \n\n \n \nThe first steps were to re-form management and attract new directors who not only understand our vision and goals, but had the wherewithal to add value in support of our vision and goals. The founders are committed to creating a dynamic and independent board of directors. We will continue to build our board in 2020 by adding experienced and ethical directors with a high value-add. Corporate \n\n \...